GAFFX
Price
$77.91
Change
-$0.26 (-0.33%)
Updated
Jun 5 closing price
Net Assets
305.91B
PGIAX
Price
$34.67
Change
+$0.13 (+0.38%)
Updated
Jun 4 closing price
Net Assets
657.94M
Interact to see
Advertisement

GAFFX vs PGIAX

Header iconGAFFX vs PGIAX Comparison
Open Charts GAFFX vs PGIAXBanner chart's image
American Funds Growth Fund of Amer F3
Price$77.91
Change-$0.26 (-0.33%)
VolumeN/A
Net Assets305.91B
Putnam Focused Equity A
Price$34.67
Change+$0.13 (+0.38%)
VolumeN/A
Net Assets657.94M
GAFFX vs PGIAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GAFFX vs. PGIAX commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GAFFX is a StrongBuy and PGIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GAFFX has more cash in the bank: 306B vs. PGIAX (658M). GAFFX pays higher dividends than PGIAX: GAFFX (0.65) vs PGIAX (0.10). GAFFX was incepted earlier than PGIAX: GAFFX (8 years) vs PGIAX (16 years). PGIAX (1.11) is less costly to investors than GAFFX (0.30). PGIAX is a more actively managed with annual turnover of: 30.00 vs. GAFFX (25.00). PGIAX has a lower initial minimum investment than GAFFX: PGIAX (0) vs GAFFX (1000000). GAFFX annual gain was more profitable for investors over the last year : 9.03 vs. PGIAX (4.70). PGIAX return over 5 years is better than : 61.23 vs. GAFFX (46.12).
GAFFXPGIAXGAFFX / PGIAX
Total Expense Ratio0.301.1127%
Annual Report Gross Expense Ratio0.301.1127%
Fund Existence8 years16 years-
Gain YTD4.9681.978251%
Front LoadN/A6%-
Min. Initial Investment10000000-
Min. Initial Investment IRAN/AN/A-
Net Assets306B658M46,505%
Annual Yield % from dividends0.650.10684%
Returns for 1 year9.034.70192%
Returns for 3 years38.8632.50120%
Returns for 5 years46.1261.2375%
Returns for 10 yearsN/A108.60-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KYMR47.663.40
+7.68%
Kymera Therapeutics
PMCB1.120.03
+2.29%
PharmaCyte Biotech
GFI25.420.38
+1.52%
Gold Fields Ltd
RMAX7.610.03
+0.40%
Re/Max Holdings
CLW29.40-0.21
-0.71%
Clearwater Paper Corp